Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retina Consultants of Texas provides comprehensive medical and surgical care for a wide range of retinal conditions. The group operates three certified research centers with over a hundred active clinical trials at any time. They have contributed to pivotal studies leading to FDA approval for major retina drugs such as ranibizumab ("Lucentis") and aflibercept ("Eylea"). Their outcomes are considered among the best nationally due to advanced technology adoption and highly trained staff.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retina Consultants of Texas.